Search

everythinglearnresearchcommunity

for

Search:↓

Cyclic ADP-ribose helps regulate calcium and signals that promote hair growth in hair follicle cells.

The new biodegradable nanocarriers safely and effectively deliver drugs into the skin.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Dimeric peptide derivatives could help hair growth and treat hair loss safely.

Allopregnanolone, a progesterone metabolite, helps reduce restraint effects on behavior.

The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.

Blocking allopregnanolone production in mice makes them more anxious after stress, but this can be reversed with a drug that mimics allopregnanolone.

Platelet-rich plasma (PRP) significantly improves long-lasting post-viral smell dysfunction.

PLA2R1 overexpression harms kidney cells by stopping their growth cycle.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Two L-PRP treatments improve hair density in mild to moderate alopecia.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

iPSC-derived artificial platelets show promise for consistent and effective regenerative therapies.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

PRP, especially AA-PRP, can help improve hair growth in androgenetic alopecia.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

PP405 may help hair growth by activating hair follicle stem cells.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Presurgical models can effectively and affordably screen cancer prevention agents.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.